News Sentiment

RNXT sentiment intelligence

RenovoRx Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.87 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-7.0% over one week, -5.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

RenovoRx, Inc. Net Income (RNXT)

Market Reaction

Price moving ahead of tone

57/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction -7.0% Price reacting lower
Trend fit Trend inactive -5.9% over four weeks
Fair value -24.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 37
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 11
Market source 7
TradingKey 7
Stock Titan 5
GlobeNewswire 5
simplywall.st 4
dars.gov.et 3
The Globe and Mail 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 26
Balance sheet 2
Guidance 2
Regulatory and legal 1
Capital return 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 60
MLQ.ai Direct company coverage

RenovoRx, Inc. Net Income (RNXT)

RenovoRx, Inc.'s net income was -$11.2M in FY2025, an increase from -$8.8M in FY2024, with the most recent quarter (Q1 FY26) showing a net income of -$3.5M. The article provides detailed annual and quarterly financial figures, including net income, operating income, and revenue,

Tone
Negative 20/100
Event
Earnings
Published
09 Jul 2026 09:43
Source
MLQ.ai
Finviz Direct company coverage

RNXT - RenovoRx Inc Latest SEC Filings

This article provides the latest SEC filing information for RenovoRx Inc (RNXT), detailing various financial metrics, performance indicators, and company statistics. It includes data on market capitalization, enterprise value, income, sales, EPS, insider and institutional ownersh

Tone
Negative 41/100
Event
Earnings
Published
04 Jul 2026 12:40
Source
Finviz
The Globe and Mail Direct company coverage

RenovoRx Granted Extended Nasdaq Compliance Period Amid Listing Risk

RenovoRx (RNXT) has received an extended compliance period from Nasdaq until December 28, 2026, to regain the minimum $1.00 bid price requirement, following an initial notice in December 2025. Failure to meet this condition could lead to delisting, though the company retains appe

Tone
Negative 32/100
Event
Market update
Published
04 Jul 2026 08:12
Source
The Globe and Mail
The Globe and Mail Direct company coverage

RenovoRx Stockholders Approve Directors and Equity Plan

RenovoRx stockholders approved the election of seven directors and an amendment to the company's 2021 Omnibus Equity Incentive Plan, adding 2,000,000 shares for equity-based compensation. They also ratified the appointment of Frank, Rimerman + Co. LLP as the independent registere

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 18:09
Source
The Globe and Mail
Minichart Direct company coverage

RenovoRx Receives Nasdaq Delisting Notice: Key Details from Latest 8-K Filing

RenovoRx, Inc. (RNXT) has received an extension from Nasdaq until December 28, 2026, to regain compliance with the minimum bid price requirement of $1.00. The company initially had until June 30, 2026, but was granted an additional 180 days. This extension provides temporary reli

Tone
Negative 31/100
Event
Market update
Published
02 Jul 2026 13:40
Source
Minichart
TradingView Direct company coverage

RenovoRx Received Notice of Noncompliance

RenovoRx (RNXT) was notified by Nasdaq on July 1, 2026, that it remains noncompliant with the $1.00 minimum bid price rule. The company has been granted a second 180-day period until December 28, 2026, to regain compliance. Failure to maintain a bid price of at least $1.00 for 10

Tone
Negative 23/100
Event
Market update
Published
02 Jul 2026 12:40
Source
TradingView
Stock Titan Direct company coverage

Nasdaq grants RenovoRx (RNXT) new deadline to fix $1 bid price

RenovoRx (RNXT) has been granted a second 180-day extension by Nasdaq, until December 28, 2026, to regain compliance with the $1.00 minimum bid price requirement. To meet this, the company's stock must close at or above $1.00 for at least 10 consecutive business days. Failure to

Tone
Negative 29/100
Event
Market update
Published
01 Jul 2026 17:40
Source
Stock Titan
Stock Titan Direct company coverage

RenovoRx (RNXT) investors approve directors, expand equity plan and ratify 2026 auditor

RenovoRx, Inc. (RNXT) stockholders have approved the election of all seven director nominees, expanded the 2021 Omnibus Equity Incentive Plan by adding 2,000,000 shares, and ratified Frank, Rimerman + Co. LLP as the independent registered public accounting firm for the year endin

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 05:07
Source
Stock Titan
TradingView Direct company coverage

RenovoRx, Inc. Financial Disclosures & SEC Filings

This article provides an extensive list of RenovoRx, Inc.'s SEC filings and other corporate documents, including earnings reports, investor presentations, and conference transcripts from 2024 through 2026. These disclosures detail the company's financial performance, operational

Tone
Positive 71/100
Event
Earnings
Published
01 Jul 2026 00:09
Source
TradingView
TradingKey Direct company coverage

RenovoRx Inc (RNXT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of RenovoRx Inc (RNXT), noting its current valuation score of 6.02, which ranks it 194 out of 203 in the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio of -2.85, indicating it is significantly bel

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 04:10
Source
TradingKey
TradingView Direct company coverage

Price to book forward of RenovoRx, Inc. – NASDAQ:RNXT

This article provides financial data for RenovoRx, Inc. (NASDAQ: RNXT), specifically focusing on its "Price to book forward" metric. It appears to be a stub or a section of a larger financial information page on TradingView. The page lacks detailed analysis, indicating that it se

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 03:41
Source
TradingView
TradingView Direct company coverage

RNXT Forecast — Price Target — Prediction for 2027

This article provides a forecast and various financial details for RenovoRx, Inc. (RNXT) stock, including analyst price targets, current stock performance, and historical data. It also summarizes the company's recent earnings, revenue, and other financial metrics, noting its mark

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 03:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of RenovoRx, Inc. – NASDAQ:RNXT

This article provides a brief financial overview for RenovoRx, Inc. (NASDAQ: RNXT) focusing on its enterprise value to revenue forward metric. It appears to be a stub or placeholder from TradingView, indicating specific financial data for the company. The content also includes ex

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 19:09
Source
TradingView
TradingView Direct company coverage

RenovoRx, Inc. Actuals & Estimates (NASDAQ:RNXT)

This article provides an overview of RenovoRx, Inc. (NASDAQ:RNXT) stock, including its current price, historical performance, analyst forecasts, and financial metrics. It details the company's market capitalization, earnings, revenue, and EBITDA, along with future earnings report

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 06:09
Source
TradingView
Investing.com South Africa Direct company coverage

Form 4 RenovoRx Inc For: 24 June By Investing.com

The article reports on a Form 4 filing for RenovoRx Inc. (RNXT) for June 24, as published by Investing.com. It is a brief announcement without further details within the provided text, indicating a standard regulatory disclosure.

Tone
Neutral 50/100
Event
Regulatory and legal
Published
25 Jun 2026 22:14
Source
Investing.com South Africa
TradingView Direct company coverage

Enterprise value to EBITDA forward of RenovoRx, Inc. – NASDAQ:RNXT

This article focuses on the enterprise value to EBITDA forward for RenovoRx, Inc. (NASDAQ: RNXT). It appears to be a financial data page from TradingView, indicating that the market for RNXT was closed with no trades at the time of access. The primary content is a statement about

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:33
Source
TradingView
Stock Titan Direct company coverage

RenovoRx (RNXT) director reorganizes indirect share holdings via trust

RenovoRx director Una S. Ryan has restructured her indirect shareholdings in the company through The Una S. Ryan Revocable Trust. This involved 97,165 shares from distributions by Astria Fund and Golden Seeds Venture Fund GP, where Ryan is a non-managing member. These "other" tra

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 21:10
Source
Stock Titan
TradingView Direct company coverage

RNXT: Strong commercial growth and clinical data position the therapy for major impact in cancer care

The article highlights RenovoRx, Inc. (RNXT) for its novel cancer therapy device, which shows strong commercial growth, rapid adoption in top medical centers, and positive interim clinical data demonstrating improved survival and reduced toxicity. The company expects to reach bre

Tone
Positive 73/100
Event
Guidance
Published
23 Jun 2026 17:40
Source
TradingView
MSN Direct company coverage

RenovoRx, Inc. (RNXT) reports Q1 loss, tops revenue estimates

This article focuses on RenovoRx, Inc. (RNXT)'s Q1 financial results. The company reported a loss per share of $-0.26, which is higher than the analyst estimate of $-0.39. Additionally, RenovoRx surpassed revenue expectations, bringing in $0.78 million compared to the estimated $

Tone
Positive 60/100
Event
Earnings
Published
22 Jun 2026 10:11
Source
MSN
TradingKey Direct company coverage

RenovoRx Inc (RNXT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article discusses RenovoRx Inc (RNXT)'s revenue breakdown, specifically addressing business segments, regional revenue, and profit contribution. However, the critical financial data for these categories has not yet been disclosed by the company, rendering the sections current

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 04:09
Source
TradingKey
TradingKey Direct company coverage

RenovoRx Inc (RNXT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of RenovoRx Inc (RNXT) stock, focusing on its dividend and stock split history. It indicates that the company has not distributed any dividends in the past five years and has no record of stock splits. The piece presents current stock data includ

Tone
Neutral 50/100
Event
Capital return
Published
19 Jun 2026 03:09
Source
TradingKey
TradingKey Direct company coverage

RenovoRx Inc (RNXT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of RenovoRx Inc (RNXT), including major shareholders and institutional holdings. It lists key individual and institutional investors, their proportion of shares, and changes in their holdings over time. The data provides insight into

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 00:40
Source
TradingKey
TradingKey Direct company coverage

RenovoRx Inc (RNXT) Institutional Confidence

RenovoRx Inc (RNXT) has an institutional shareholding score of 3.00, placing it 132nd out of 203 in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 20.02%, showing a slight quarter-over-quarter decrease. James Simons is identified as the

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 00:39
Source
TradingKey
TradingKey Direct company coverage

RenovoRx Inc (RNXT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of RenovoRx Inc (RNXT), focusing on its price momentum, support and resistance levels, and key indicators like MACD, RSI, and moving averages. As of June 18, 2026, the stock's price momentum score is 7.09, suggesting suitability for rang

Tone
Positive 62/100
Event
Market update
Published
18 Jun 2026 12:10
Source
TradingKey
TradingKey Direct company coverage

RenovoRx Inc (RNXT) Earnings Forecast: Future EPS & Revenue Growth Estimates

RenovoRx Inc (RNXT) has an earnings forecast score of 8.00, placing it 66th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $3.50, with a high of $12.50 and a low of $3.00. Based on ratings from four analysts, most recommend a "Buy" t

Tone
Positive 70/100
Event
Earnings
Published
17 Jun 2026 19:19
Source
TradingKey
Investing News Network Direct company coverage

RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP in Locally Advanced Pancreatic Cancer

RenovoRx announced the publication of a peer-reviewed case study from Moffitt Cancer Center in Radiology Case Reports. The study highlights the successful intra-arterial delivery of gemcitabine via RenovoCath in a patient with locally advanced pancreatic cancer, showcasing a new

Tone
Positive 72/100
Event
Market update
Published
11 Jun 2026 18:41
Source
Investing News Network